Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001203536 | SCV001374705 | uncertain significance | Charcot-Marie-Tooth disease type 4 | 2022-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 268 of the NDRG1 protein (p.Ala268Ser). This variant is present in population databases (rs752290896, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with NDRG1-related conditions. ClinVar contains an entry for this variant (Variation ID: 935032). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002411743 | SCV002675983 | uncertain significance | Inborn genetic diseases | 2021-07-14 | criteria provided, single submitter | clinical testing | The p.A268S variant (also known as c.802G>T), located in coding exon 11 of the NDRG1 gene, results from a G to T substitution at nucleotide position 802. The alanine at codon 268 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001833790 | SCV002085035 | uncertain significance | Charcot-Marie-Tooth disease type 4D | 2020-12-14 | no assertion criteria provided | clinical testing |